Hikma Pharmaceuticals PLC (HKMPF)

Market Cap	5.79B
Revenue (ttm)	3.13B
Net Income (ttm)	359.00M
Shares Out	n/a
EPS (ttm)	1.61
PE Ratio	16.12
Forward PE	n/a
Dividend	0.80 (2.91%)
Ex-Dividend Date	Mar 20, 2025

Volume	200
Average Volume	1,200
Open	27.51
Previous Close	n/a
Day's Range	27.51 - 27.51
52-Week Range	21.28 - 27.00
Beta	0.45
RSI	56.33
Earnings Date	Feb 26, 2025

About Hikma Pharmaceuticals

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various th...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1978
• Employees: 9,500
• Stock Exchange: OTCMKTS
• Ticker Symbol: HKMPF

Financial Performance

In 2024, Hikma Pharmaceuticals's revenue was $3.13 billion, an increase of 8.77% compared to the previous year's $2.88 billion. Earnings were $359.00 million, an increase of 88.95%.